Gujilde, Celso M.
HRN: 21-41-61 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/01/2022
PIPERACILLIN + TAZOBACTAM 4.5G (VLS)
06/01/2022
06/08/2022
IV
4.5g
Q6hours
CAP-HR
Waiting Final Action
Indication: Empiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes